Perspective Therapeutics

CATX • NYSE •
Overview Stats Financials News

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range $0.21-$1.90
Market Cap $1B
Shares Short 15M

Financials

See more
Revenue (12 Mos) $1.5M
Revenue Growth (YoY) -84.2%
Gross Profit (12 Mos) $0
Diluted EPS -$0.17

News

See more

Yahoo Finance • 8 months ago

Perspective Therapeutics’ VMT-α-NET Protocols Presented at the North American Neuroendocrine Tumor Society (NANETS) 2023 Symposium

Yahoo Finance • 9 months ago

Perspective Announces Presentation of Positive Early Clinical Data for VMT-α-NET at the 36th Annual Congress of the European Association of Nuclear Medicine

Yahoo Finance • 9 months ago

Perspective Therapeutics to Present Clinical and Preclinical Data at the 36th Annual Congress of the European Association of Nuclear Medicine

Yahoo Finance • a year ago

Perspective Therapeutics’ Cesium-131 Featured at the American Brachytherapy Society’s Annual Conference

About

CEO Mr. Johan M. Spoor
CFO Mr. Jonathan R. Hunt
Address 2401 Elliott Avenue, Seattle, WA, United States, 98121
Sector Healthcare
Industry Medical Devices
Full-Time Employees 116